Skip to main content
HairCited

描述

Risk of bias assessment for randomized controlled trials included in the PRP meta-analysis for androgenetic alopecia, evaluating methodological quality across domains such as randomization, blinding, and outcome reporting.

Cite This Figure

![Figure 2: Risk of bias assessment for randomized controlled trials included in the PRP meta-analysis for androgenetic alopecia, evaluating methodological quality across domains such as randomization, blinding, and outcome reporting.]()

> Source: Meijia Li et al. "Effectiveness of Platelet-Rich Plasma in the Treatment of Androgenic Alopecia: A." *Aesthetic plastic surgery*, 2024. PMID: [37644190](https://pubmed.ncbi.nlm.nih.gov/37644190/)
<figure>
  <img src="" alt="Risk of bias assessment for randomized controlled trials included in the PRP meta-analysis for androgenetic alopecia, evaluating methodological quality across domains such as randomization, blinding, and outcome reporting." />
  <figcaption>Figure 2. Risk of bias assessment for randomized controlled trials included in the PRP meta-analysis for androgenetic alopecia, evaluating methodological quality across domains such as randomization, blinding, and outcome reporting.<br>  Source: Meijia Li et al. "Effectiveness of Platelet-Rich Plasma in the Treatment of Androgenic Alopecia: A." <em>Aesthetic plastic surgery</em>, 2024. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/37644190/">37644190</a></figcaption>
</figure>